Citigroup’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Sell |
21,970
-110,723
| -83% | -$5.84M | ﹤0.01% | 3086 |
|
|
2025
Q4 | $6.96M | Buy |
132,693
+72,204
| +119% | +$4.32M | ﹤0.01% | 1787 |
|
|
2025
Q3 | $3.92M | Sell |
60,489
-66,403
| -52% | -$3.81M | ﹤0.01% | 2149 |
|
|
2025
Q2 | $6.17M | Sell |
126,892
-78,756
| -38% | -$3.05M | ﹤0.01% | 1728 |
|
|
2025
Q1 | $7M | Buy |
205,648
+95,292
| +86% | +$4.04M | 0.01% | 1629 |
|
|
2024
Q4 | $4.34M | Buy |
110,356
+85,934
| +352% | +$4.06M | ﹤0.01% | 2111 |
|
|
2024
Q3 | $1.15M | Sell |
24,422
-13,682
| -36% | -$694K | ﹤0.01% | 3156 |
|
|
2024
Q2 | $2.06M | Sell |
38,104
-63,365
| -62% | -$3.67M | ﹤0.01% | 2331 |
|
|
2024
Q1 | $6.92M | Sell |
101,469
-9,616
| -9% | -$688K | 0.01% | 1498 |
|
|
2023
Q4 | $6.95M | Sell |
111,085
-1,026
| -0.9% | -$56.7K | 0.01% | 1396 |
|
|
2023
Q3 | $5.09M | Buy |
112,111
+3,617
| +3% | +$187K | 0.01% | 1421 |
|
|
2023
Q2 | $6.09M | Sell |
108,494
-82,521
| -43% | -$4.68M | 0.01% | 1378 |
|
|
2023
Q1 | $8.64M | Buy |
191,015
+66,067
| +53% | +$3.21M | 0.01% | 1226 |
|
|
2022
Q4 | $5.08M | Buy |
124,948
+8,354
| +7% | +$443K | 0.01% | 1469 |
|
|
2022
Q3 | $7.62M | Buy |
116,594
+25,340
| +28% | +$1.84M | 0.01% | 1292 |
|
|
2022
Q2 | $5.55M | Buy |
91,254
+60,876
| +200% | +$3.58M | 0.01% | 1480 |
|
|
2022
Q1 | $1.91M | Sell |
30,378
-410
| -1% | -$25.7K | ﹤0.01% | 2391 |
|
|
2021
Q4 | $2.33M | Buy |
30,788
+2,275
| +8% | +$199K | ﹤0.01% | 2489 |
|
|
2021
Q3 | $3.19M | Sell |
28,513
-4,648
| -14% | -$584K | ﹤0.01% | 2134 |
|
|
2021
Q2 | $5.37M | Buy |
33,161
+7,135
| +27% | +$868K | ﹤0.01% | 1838 |
|
|
2021
Q1 | $3.17M | Buy |
26,026
+4,765
| +22% | +$719K | ﹤0.01% | 2156 |
|
|
2020
Q4 | $3.26M | Sell |
21,261
-14,151
| -40% | -$1.67M | ﹤0.01% | 2408 |
|
|
2020
Q3 | $2.96M | Sell |
35,412
-9,802
| -22% | -$869K | ﹤0.01% | 2304 |
|
|
2020
Q2 | $3.32M | Sell |
45,214
-14,489
| -24% | -$847K | ﹤0.01% | 2251 |
|
|
2020
Q1 | $2.53M | Buy |
59,703
+34,625
| +138% | +$1.79M | ﹤0.01% | 2261 |
|
|
2019
Q4 | $1.53M | Buy |
25,078
+15,935
| +174% | +$870K | ﹤0.01% | 3292 |
|
|
2019
Q3 | $375K | Sell |
9,143
-5,347
| -37% | -$256K | ﹤0.01% | 4610 |
|
|
2019
Q2 | $683K | Sell |
14,490
-2,466
| -15% | -$98.6K | ﹤0.01% | 4099 |
|
|
2019
Q1 | $605K | Sell |
16,956
-42
| -0.2% | -$1.45K | ﹤0.01% | 3976 |
|
|
2018
Q4 | $486K | Buy |
16,998
+5,603
| +49% | +$195K | ﹤0.01% | 4151 |
|
|
2018
Q3 | $505K | Buy |
11,395
+1,278
| +13% | +$66.9K | ﹤0.01% | 4264 |
|
|
2018
Q2 | $595K | Buy |
10,117
+8,795
| +665% | +$501K | ﹤0.01% | 3905 |
|
|
2018
Q1 | $61K | Buy |
1,322
+17
| +1% | +$702 | ﹤0.01% | 6007 |
|
|
2017
Q4 | $30K | Buy |
1,305
+1,295
| +12,950% | +$24.6K | ﹤0.01% | 6497 |
|
|
2017
Q3 | $0 | Buy |
+10
| New | +$181 | ﹤0.01% | 7271 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$2K | – | 7352 |
|
|
2017
Q1 | $2K | Buy |
+100
| New | +$1.96K | ﹤0.01% | 6987 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
